EDIT
Editas Medicine Inc
Clinical-stage biotechnology company focused on CRISPR gene editing therapies
CUSIP: 28106W103HealthcareUS1 holder
Total Value
$73.76M
Total Shares
2.14M
Net Share Change
+2.14M
Activity
1 buying
Investor
Value
Shares
Weight
Change
Viking Global Investors
$73.76M2.14M sharesNEW